Penn Medicine Head and Neck Cancer Service Line COVID-19 management guidelines.
Head Neck
; 42(7): 1507-1515, 2020 Jul.
Article
in English
| MEDLINE | ID: covidwho-614117
Semantic information from SemMedBD (by NLM)
1. 2019 novel coronavirus CAUSES COVID-19
2. Malignant Head and Neck Neoplasm PROCESS_OF Patients
3. Practitioner TREATS Patients
4. 2019 novel coronavirus CAUSES COVID-19
5. Malignant Head and Neck Neoplasm PROCESS_OF Patients
6. Practitioner TREATS Patients
ABSTRACT
INTRODUCTION:
The COVID-19 pandemic caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) virus has altered the health care environment for the management of head and neck cancers. The purpose of these guidelines is to provide direction during the pandemic for rational Head and Neck Cancer management in order to achieve a medically and ethically appropriate balance of risks and benefits.METHODS:
Creation of consensus document.RESULTS:
The process yielded a consensus statement among a wide range of practitioners involved in the management of patients with head and neck cancer in a multihospital tertiary care health system.CONCLUSIONS:
These guidelines support an ethical approach for the management of head and neck cancers during the COVID-19 epidemic consistent with both the local standard of care as well as the head and neck oncological literature.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Infection Control
/
Coronavirus Infections
/
Pandemics
/
Betacoronavirus
/
Head and Neck Neoplasms
/
Medical Oncology
Type of study:
Diagnostic study
/
Clinical Practice Guide
Limits:
Humans
Country/Region as subject:
North America
Language:
English
Journal:
Head Neck
Journal subject:
Neoplasms
Year:
2020
Document Type:
Article
Affiliation country:
Hed.26318